Viking Global Opportunities Illiquid Investments Sub-Master LP
CIK 1629482 · last filed 2024-06-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
UROV price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
FLOOR 11
STAMFORD, CT 06901
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| APG | 10%+ Owner | 0 | $40.27 | $0 | -$595.68M | 1 | 2024-06-18 |
| FDMT | 10%+ Owner | 4,787,914 | $11.03 | $52.81M | $108.80M | 1 | 2023-05-11 |
| INBX | 10%+ Owner | 333,333 | $88.61 | $29.54M | $320.00M | 1 | 2022-10-12 |
| Ginkgo Bioworks Holdings, Inc. (DNA.WS) Delisted | 10%+ Owner | 51,055,144 | $0.01 | $321.6K | $0 | 1 | 2022-03-04 |
| AMLX | 10%+ Owner | 4,870,536 | $27.09 | $131.94M | $349.60M | 1 | 2022-01-13 |
| ZNTL | 10%+ Owner | 3,943,284 | $2.07 | $8.16M | -$176.75M | 1 | 2020-12-03 |
| ADPT | 10%+ Owner | 33,493,708 | $26.27 | $879.88M | -$858.94M | 1 | 2020-01-30 |
| Myovant Sciences Ltd. (MYOV) Delisted | 10%+ Owner | 40,765,599 | $26.98 | $1.10B | $140.00M | 1 | 2019-06-13 |
| Urovant Sciences Ltd. (UROV) Delisted | 10%+ Owner | 22,740,305 | $16.24 | $369.30M | $962.34M | 2 | 2019-05-23 |
| ABUS | 10%+ Owner | — | $4.20 | — | $0 | 1 | 2017-10-17 |
| EDIT | 10%+ Owner | 2,744,880 | $2.40 | $6.59M | $0 | 1 | 2016-02-08 |
Recent Filings · Page 2 of 2
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-10-03 | Urovant Sciences Ltd. (UROV) Delisted | Buy (P) | +18,749,997 | $262.50M | EDGAR |
| 2017-10-17 | ABUS | Buy (P) | — | $0 | EDGAR |
| 2016-02-08 | EDIT | Mixed | +38,217,312 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.